Global Alliance against Chronic Respiratory Diseases

Area of Science:

• Pulmonology
• Public Health
• Global Health Initiatives

Background:

• Chronic respiratory diseases (CRDs) impact hundreds of millions worldwide, including asthma, COPD, and pulmonary hypertension.
• Prevalence of CRDs is increasing, with a disproportionate burden on developing countries and deprived populations.
• Despite significant human suffering and economic costs, CRDs and their risk factors are often overlooked by healthcare systems, policymakers, and the public.

Purpose of the Study:

• To address the insufficient attention given to chronic respiratory diseases globally.
• To establish a collaborative framework for improving global lung health.
• To outline a strategic approach for the prevention and control of CRDs, emphasizing developing countries.

Main Methods:

• Formation of the World Health Organization (WHO) Global Alliance against Chronic Respiratory Diseases (GARD) as a voluntary alliance.
• GARD operates on a common vision to enhance lung health tailored to local requirements.
• A stepwise planning approach involving needs assessment, policy development, and implementation strategies.

Main Results:

• GARD has been established as a collaborative platform involving diverse organizations and agencies.
• The alliance focuses on improving global lung health through locally relevant strategies.
• A structured, three-step planning process guides GARD's actions: needs assessment and advocacy, policy formulation, and implementation planning.

Conclusions:

• Chronic respiratory diseases represent a major global health challenge requiring urgent and coordinated action.
• The WHO Global Alliance against Chronic Respiratory Diseases (GARD) provides a vital framework for addressing this challenge.
• GARD's collaborative and stepwise approach is designed to effectively improve lung health outcomes worldwide, particularly in underserved regions.